文献速递心境障碍会诊联络精神医学

重度抑郁障碍成人全身性炎症与炎症激发后快感缺失反应:一项随机对照试验

Systemic Inflammation and Anhedonic Responses to an Inflammatory Challenge in Adults With Major Depressive Disorder: A Randomized Controlled Trial.
PubMed 文献 · Am J Psychiatry · 2025-04-23

该随机对照试验将68例重度抑郁障碍患者按基线CRP分层为高CRP(≥3 mg/L)与低CRP(≤1.5 mg/L)组,1:1随机接受LPS(0.8 ng/kg体重)或安慰剂,双盲平行分组。高CRP组接受LPS后1.5小时SHAPS快感缺失评分与IL-6较基线升幅显著大于低CRP组,TNF与IL-10无显著差异;MADRS未在1.5小时施测。作者认为伴全身性炎症的抑郁个体对炎症刺激反应更强,并影响快感缺失这一主要结局。

要点

  • 高CRP组接受LPS后1.5小时SHAPS快感缺失评分较基线升幅显著大于低CRP组。
  • 高CRP组接受LPS后1.5小时IL-6较基线升幅显著大于低CRP组,TNF与IL-10无显著差异。
  • MADRS未在1.5小时施测;二次分析显示基线至24小时高CRP组MADRS评分下降更大,驱动显著的三阶交互。

核心结论

  • 作者认为伴全身性炎症的抑郁个体似乎在生物学上更易对炎症刺激产生较强反应,这种敏化在心理层面影响快感缺失这一主要结局。

研究设计与样本

  • 68例重度抑郁障碍患者按1:1比例随机接受LPS(0.8 ng/kg体重)或安慰剂(生理盐水),采用平行分组双盲设计。
  • 按基线CRP浓度分层,形成四组:高CRP-LPS组(N=13)、低CRP-LPS组(N=19)、高CRP-安慰剂组(N=13)、低CRP-安慰剂组(N=19)。
  • 在基线、给药后1、1.5、3.5、6、24小时及1周采血并同步评估心理结局,主要结局为Snaith-Hamilton快感量表(SHAPS),主要对比为接受LPS的高CRP组与低CRP组基线至1.5小时的变化。
  • 次要结局包括蒙哥马利-奥斯伯格抑郁评定量表(MADRS)及血清白细胞介素-6(IL-6)、IL-10、肿瘤坏死因子(TNF)水平;数据分析采用线性混合模型。

主要发现

  • 接受LPS的高CRP组与低CRP组相比,基线至1.5小时自报快感缺失(SHAPS)与IL-6水平的升幅显著更大。
  • TNF与IL-10在两组间无显著差异。
  • MADRS未在1.5小时施测;二次分析显示存在显著的组×条件×时间交互,由高CRP组基线至24小时MADRS评分下降更大所驱动。

关键数值与推荐

  • 高CRP定义为血清CRP≥3 mg/L,低CRP定义为≤1.5 mg/L。
  • LPS剂量为0.8 ng/kg体重。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors sought to determine whether an inflammatory challenge with lipopolysaccharide (LPS) differentially impacts symptoms of anhedonia in participants with major depressive disorder with high (≥3 mg/L) and low (≤1.5 mg/L) serum C-reactive protein (CRP) concentrations. METHODS: Sixty-eight participants with major depressive disorder were randomly assigned, in a 1:1 ratio, to receive LPS (0.8 ng/kg body weight) or placebo (saline) in a parallel-group double-blind design. Participants were stratified according to baseline CRP concentrations, yielding four groups: high-CRP LPS (N=13), low-CRP LPS (N=19), high-CRP placebo (N=13), and low-CRP placebo (N=19). Blood was sampled at baseline, at 1, 1.5, 3.5, 6, and 24 hours, and 1 week after LPS or saline administration, with concurrent assessment of psychological outcomes. The primary outcome measure was the Snaith-Hamilton Pleasure Scale (SHAPS), and the primary contrast of interest was the change between baseline and 1.5 hours (peak of the inflammatory response) in the high-CRP versus low-CRP groups receiving LPS. Secondary outcomes included the Montgomery-Åsberg Depression Rating Scale (MADRS) and serum levels of three cytokines: interleukin-6 (IL-6), IL-10, and tumor necrosis factor (TNF). Data were analyzed with linear mixed models. RESULTS: Significantly greater increases in self-reported anhedonia (on the SHAPS) and IL-6 levels were observed between baseline and 1.5 hours in the high-CRP versus low-CRP LPS groups. There were no significant differences for TNF and IL-10. The MADRS was not administered at 1.5 hours; secondary analyses showed a significant group-by-condition-by-time interaction driven by a greater decrease in MADRS scores between baseline and 24 hours in the high-CRP group. CONCLUSIONS: Depressed individuals with systemic inflammation appeared to be biologically primed to respond more strongly to inflammatory stimuli, and psychologically, this sensitization impacted the symptom of anhedonia, the primary outcome.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Savitz J, Figueroa-Hall LK, Teague TK, et al. Systemic Inflammation and Anhedonic Responses to an Inflammatory Challenge in Adults With Major Depressive Disorder: A Randomized Controlled Trial. Am J Psychiatry. 2025. PMID: 40264292. doi:10.1176/appi.ajp.20240142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。